NXGL

What one share of Nexgel holds

Surgical and Medical Instruments and Apparatus

We manufacture high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound

Nexgel’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$1.46
Profit−$0.75
Cash and investments$0.18
Debt$0.06
Book value$0.51

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2018$15.47−$13.20————
2019$1.85−$4.96$0.00−$4.68——
2020$0.30−$1.05$0.14−$0.94—$0.03
2021$0.52−$1.45$0.09−$1.01—$2.17
2022$0.37−$0.85$0.02−$0.55—$1.37
2023$0.72−$0.56$0.12−$0.69—$0.82
2024$1.33−$0.50$0.07−$0.66—$0.75
2025$1.45−$0.38$0.01−$0.18—$0.55

Common questions about Nexgel

How much does one share of Nexgel earn?

Over the last 12 months, Nexgel lost $0.75 for each share on $1.46 of sales.

Does Nexgel pay a dividend?

Nexgel didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Nexgel’s book value per share?

Nexgel’s book value is $0.51 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Nexgel have?

Each share of Nexgel has $0.18 of cash and investments and $0.06 of debt, as of June 30, 2026.

Has Nexgel bought back shares?

Nexgel’s share count rose about 5392% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.